Biogen (BIIB) earnings Q4 2024

Biogen (BIIB) earnings Q4 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth.  But the biotech company’s…

Read More
Back To Top